Aura Biosciences, Inc. (AURA) financial statements (2022 and earlier)

Company profile

Business Address 85 BOLTON STREET
CAMBRIDGE, MA 02140
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments149,063
Cash and cash equivalents149,063
Restricted cash and investments23
Prepaid expense2,734
Other current assets66
Other undisclosed current assets1,818
Total current assets:153,704
Noncurrent Assets
Operating lease, right-of-use asset950
Property, plant and equipment5,251
Restricted cash and investments125
Total noncurrent assets:6,326
TOTAL ASSETS:160,030
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities4,971
Accounts payable2,401
Accrued liabilities423
Employee-related liabilities2,147
Other undisclosed current liabilities2,301
Total current liabilities:7,272
Noncurrent Liabilities
Long-term debt and lease obligation360
Operating lease, liability360
Other undisclosed noncurrent liabilities(277)
Total noncurrent liabilities:443
Total liabilities:7,715
Stockholders' equity
Stockholders' equity attributable to parent152,315
Additional paid in capital304,452
Accumulated deficit(152,137)
Total stockholders' equity:152,315
TOTAL LIABILITIES AND EQUITY:160,030

Income statement (P&L) ($ in thousands)

12/31/2021
Operating expenses(35,250)
Operating loss:(35,250)
Nonoperating expense(1)
Net loss attributable to parent:(35,251)
Preferred stock dividends and other adjustments(10,942)
Net loss available to common stockholders, diluted:(46,193)

Comprehensive Income ($ in thousands)

12/31/2021
Net loss:(35,251)
Comprehensive loss, net of tax, attributable to parent:(35,251)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: